awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36782811-012DB7C6-1BE8-41B9-AB49-F94F7259F61B
Q36782811-012DB7C6-1BE8-41B9-AB49-F94F7259F61B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36782811-012DB7C6-1BE8-41B9-AB49-F94F7259F61B
Once-weekly exenatide versus once- or twice-daily insulin detemir: randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas
P2860
Q36782811-012DB7C6-1BE8-41B9-AB49-F94F7259F61B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36782811-012DB7C6-1BE8-41B9-AB49-F94F7259F61B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d655423731be3f910878e0937e1b0d83bab14cea
P2860
Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study.